Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 7

Results: 37

Significance of chemokine receptor expression in aggressive NK cell leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1169, doi. 10.1038/sj.leu.2403732

By:

Makishima, H.;
Ito, T.;
Asano, N.;
Nakazawa, H.;
Shimodaira, S.;
Kamijo, Y.;
Nakazawa, Y.;
Suzuki, T.;
Kobayashi, H.;
Kiyosawa, K.;
Ishida, F.

Publication type:

Article

Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-α.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1239, doi. 10.1038/sj.leu.2403734

By:

Jiang, Y.;
Xue, Z.-H.;
Shen, W.-Z.;
Du, K.-M.;
Yan, H.;
Yu, Y.;
Peng, Z.-G.;
Song, M.-G.;
Tong, J.-H.;
Chen, Z.;
Huang, Y.;
Lübbert, M.;
Chen, G.-Q.

Publication type:

Article

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1216, doi. 10.1038/sj.leu.2403748

By:

Heintel, D.;
Kienle, D.;
Shehata, M.;
Kröber, A.;
Kroemer, E.;
Schwarzinger, I.;
Mitteregger, D.;
Le, T.;
Gleiß, A.;
Mannhalter, C.;
Chott, A.;
Schwarzmeier, J.;
Fonatsch, C.;
Gaiger, A.;
Döhner, H.;
Stilgenbauer, S.;
Jäger, U.

Publication type:

Article

Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation.

Published in:

2005

By:

Lange, T.;
Bumm, T.;
Mueller, M.;
Otto, S.;
Al-Ali, H.-K.;
Grommisch, L.;
Musiol, S.;
Franke, C.;
Krahl, R.;
Niederwieser, D.;
Deininger, M. W. N.

Publication type:

Letter

TEL/AML1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL.

Published in:

2005

By:

Fronkova, E.;
Madzo, J.;
Zuna, J.;
Reznickova, L.;
Muzikova, K.;
Hrusak, O.;
Stary, J.;
Trka, J.

Publication type:

Letter

Identification of e19a2 BCR–ABL fusions (μ-BCR breakpoints) at the DNA level by ligation-mediated PCR.

Published in:

2005

By:

Boeckx, N.;
Jansen, M. W. J. C.;
Haskovec, C.;
Vandenberghe, P.;
van der Velden, V. H. J.;
van Dongen, J. J. M.

Publication type:

Letter

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL – Inhibition of P-glycoprotein function by 17-AAG.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1198, doi. 10.1038/sj.leu.2403764

By:

Radujkovic, A.;
Schad, M.;
Topaly, J.;
Veldwijk, M. R.;
Laufs, S.;
Schultheis, B. S.;
Jauch, A.;
Melo, J. V.;
Fruehauf, S.;
Zeller, W. J.

Publication type:

Article

T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression.

Published in:

2005

By:

Herishanu, Y.;
Kay, S.;
Rogowski, O.;
Pick, M.;
Naparstek, E.;
Deutsch, V. R.;
Polliack, A.

Publication type:

Letter

Expression profile of survivin in acute leukaemias: the importance of differential splicing.

Published in:

2005

By:

Lopes, R.;
Castro, I.;
Pontes, P.;
Candeias, J.;
Lemoine, N. R.;
Sambade, C.

Publication type:

Letter

MLL methylation is not likely a common mechanism for therapy-related AML.

Published in:

2005

By:

Bogni, A.;
Pui, C.-H.;
Relling, M. V.

Publication type:

Letter

CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.

Published in:

2005

By:

van Zutven, L. J. C. M.;
van Drunen, E.;
de Bont, J. M.;
Wattel, M. M.;
Den Boer, M. L.;
Pieters, R.;
Hagemeijer, A.;
Slater, R. M.;
Beverloo, H. B.

Publication type:

Letter

The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1161, doi. 10.1038/sj.leu.2403773

By:

Trus, M. R.;
Yang, L.;
Saiz, F. Suarez;
Bordeleau, L.;
Jurisica, I.;
Minden, M. D.

Publication type:

Article

Maintained rules of development in a mouse B-cell tumor.

Published in:

2005

By:

Robbiani, D. F.;
Colon, K.;
Affer, M.;
Chesi, M.;
Bergsagel, P. L.

Publication type:

Letter

Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies.

Published in:

2005

By:

Gambacorti-Passerini, C.;
Gasser, M.;
Ahmed, S.;
Assouline, S.;
Scapozza, L.

Publication type:

Letter

Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1253, doi. 10.1038/sj.leu.2403776

By:

Kumar, S.;
Raje, N.;
Hideshima, T.;
Ishitsuka, K.;
Roccaro, A.;
Shiraishi, N.;
Hamasaki, M.;
Yasui, H.;
Munshi, N. C.;
Richardson, P.;
Figg, W. D.;
Anderson, K. C.

Publication type:

Article

Predicting the effect of transcription therapy in hematologic malignancies.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1109, doi. 10.1038/sj.leu.2403777

By:

Melnick, A.

Publication type:

Article

Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL).

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1211, doi. 10.1038/sj.leu.2403778

By:

Winkler, D.;
Schneider, C.;
Kröber, A.;
Pasqualucci, L.;
Lichter, P.;
Döhner, H.;
Stilgenbauer, S.

Publication type:

Article

Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1192, doi. 10.1038/sj.leu.2403779

By:

Giehl, M.;
Fabarius, A.;
Frank, O.;
Hochhaus, A.;
Hafner, M.;
Hehlmann, R.;
Seifarth, W.

Publication type:

Article

Centrosome aberrations – hen or egg in cancer initiation and progression?

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1142, doi. 10.1038/sj.leu.2403780

By:

Krämer, A.

Publication type:

Article

Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1229, doi. 10.1038/sj.leu.2403781

By:

Semmes, O. J.;
Cazares, L. H.;
Ward, M. D.;
Qi, L.;
Moody, M.;
Maloney, E.;
Morris, J.;
Trosset, M. W.;
Hisada, M.;
Gygi, S.;
Jacobson, S.

Publication type:

Article

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1207, doi. 10.1038/sj.leu.2403782

By:

Lin, T. S.;
Flinn, I. W.;
Lucas, M. S.;
Porcu, P.;
Sickler, J.;
Moran, M. E.;
Lucas, D. M.;
Heerema, N. A.;
Grever, M. R.;
Byrd, J. C.

Publication type:

Article

The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1145, doi. 10.1038/sj.leu.2403783

By:

Aricó, M.;
Baruchel, A.;
Bertrand, Y.;
Biondi, A.;
Conter, V.;
Eden, T.;
Gadner, H.;
Gaynon, P.;
Horibe, K.;
Hunger, S. P.;
Janka-Schaub, G.;
Masera, G.;
Nachman, J.;
Pieters, R.;
Schrappe, M.;
Schmiegelow, K.;
Valsecchi, M. G.;
Pui, C.-H.

Publication type:

Article

Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1248, doi. 10.1038/sj.leu.2403784

By:

Wuillème-Toumi, S.;
Robillard, N.;
Gomez, P.;
Moreau, P.;
Le Gouill, S.;
Avet-Loiseau, H.;
Harousseau, J.-L.;
Amiot, M.;
Bataille, R.

Publication type:

Article

Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.

Published in:

2005

By:

Jørgensen, H. G.;
Allan, E. K.;
Graham, S. M.;
Godden, J. L.;
Richmond, L.;
Elliott, M. A.;
Mountford, J. C.;
Eaves, C. J.;
Holyoake, T. L.;
Jørgensen, H G

Publication type:

journal article

Occurrence of de novo ABL kinase domain mutations in primary bone marrow cells after BCR-ABL gene transfer and Imatinib mesylate selection.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1265, doi. 10.1038/sj.leu.2403786

By:

Flamant, S.;
Turhan, A. G.

Publication type:

Article

Transcriptional regulation of parathyroid hormone-related protein promoter P3 by ETS-1 in adult T-cell leukemia/lymphoma.

Published in:

2005

By:

Richard, V.;
Nadella, M. V. P.;
Green, P. L.;
Lairmore, M. D.;
Feuer, G.;
Foley, J. G.;
Rosol, T. J.

Publication type:

journal article

Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia.

Published in:

2005

By:

Sellick, G S;
Spendlove, H E;
Catovsky, D;
Pritchard-Jones, K;
Houlston, R S

Publication type:

Letter

Human hematopoietic cell transplantation results in generation of donor-derived epithelial cells.

Published in:

2005

By:

Metaxas, Y;
Zeiser, R;
Schmitt-Graeff, A;
Waterhouse, M;
Faber, P;
Follo, M;
Bertz, H;
Finke, J;
Spyridonidis, A

Publication type:

Letter

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1153, doi. 10.1038/sj.leu.2403790

By:

Callens, C.;
Chevret, S.;
Cayuela, J.-M.;
Cassinat, B.;
Raffoux, E.;
de Botton, S.;
Thomas, X.;
Guerci, A.;
Fegueux, N.;
Pigneux, A.;
Stoppa, A.-M.;
Lamy, T.;
Rigal-Huguet, F.;
Vekhoff, A.;
Meyer-Monard, S.;
Ferrand, A.;
Sanz, M.;
Chomienne, C.;
Fenaux, P.;
Dombret, H.

Publication type:

Article

Treatment of relapsed acute myelogeneous leukaemia with MLL/AF6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy.

Published in:

2005

By:

Schuster, F R;
Führer, M;
Woessmann, W;
Reiter, A;
Harbott, J;
Viehmann, S;
Borkhardt, A

Publication type:

Letter

Reply to Schuster et al.

Published in:

2005

By:

Schmid, C.;
Kolb, H.-J.

Publication type:

Letter

Leukemia-derived dendritic cells in acute myeloid leukemia exhibit potent migratory capacity.

Published in:

2005

By:

Westers, T. M.;
Houtenbos, I.;
Snoijs, N. C. L.;
van de Loosdrecht, A. A.;
Ossenkoppele, G. J.

Publication type:

Letter

Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1118, doi. 10.1038/sj.leu.2403796

By:

Kucia, M.;
Reca, R.;
Jala, V. R.;
Dawn, B.;
Ratajczak, J.;
Ratajczak, M. Z.

Publication type:

Article

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1128, doi. 10.1038/sj.leu.2403797

By:

Turner, S. D.;
Alexander, D. R.

Publication type:

Article

The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?

Published in:

2005

By:

Dreger, P.;
Ritgen, M.;
Böttcher, S.;
Schmitz, N.;
Kneba, M.

Publication type:

Editorial

Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic–granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1139, doi. 10.1038/sj.leu.2403804

By:

Lichtman, M. A.

Publication type:

Article

Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.

Published in:

Leukemia (08876924), 2005, v. 19, n. 7, p. 1224, doi. 10.1038/sj.leu.2403810

By:

Schoch, C;
Kohlmann, A;
Dugas, M;
Kern, W;
Hiddemann, W;
Schnittger, S;
Haferlach, T

Publication type:

Article